D.R. Horton shares are sitting close to an important technical support area around 41.94 USD based on weekly price data. Against this backdrop, investors can use this good timing for new long positions. Investors have an opportunity to buy the stock and target the $ 53.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
The share is getting closer to its long-term support in weekly data, at USD 41.94, which offers good timing for buyers.
The company returns high margins, thereby supporting business profitability.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's attractive earnings multiples are brought to light by a P/E ratio at 12.13 for the current year.
Sales forecast by analysts have been recently revised upwards.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past twelve months, EPS forecast has been revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 41.94 USD
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.